Indications & Contraindications
Indications
- Chylous leak localization — chylothorax, chylous ascites, chyluria, lymphocele
- Pre-procedural planning for thoracic duct embolization — opacify cisterna chyli and thoracic duct to guide access
- Lymphatic mapping for lymphedema evaluation
- Post-surgical lymphatic injury evaluation (e.g., post-esophagectomy, post-thoracic surgery)
- Pleural fluid output ≥500 mL/day with triglycerides ≥110 mg/dL and/or chylomicrons present = chylous effusion
Contraindications
- Allergy to Lipiodol (ethiodized oil) or isosulfan blue dye
- Right-to-left cardiac shunt (risk of systemic oil embolism)
- Severe pulmonary disease (pulmonary oil embolism risk)
- Prior lung/mediastinal radiation (increased risk of cerebral oil embolism)
- Uncorrectable coagulopathy (for thoracic duct intervention)
Pedal vs. Intranodal Approach
| Feature | Pedal Lymphangiography | Intranodal Lymphangiography |
|---|---|---|
| Access | Cutdown on dorsal foot lymphatic after blue dye injection | US-guided 25G spinal needle into inguinal lymph node |
| Technical Difficulty | High — requires microsurgical skill, loupes | Low — straightforward US-guided puncture |
| Equipment | 30G lymphangiography needle, power injector, isosulfan blue | 25G spinal needle, connector tubing, 3 mL syringe |
| Time | 2+ hours (including cutdown and infusion) | ~50 min shorter on average |
| Preference | Historical standard | Preferred modern technique |
Pre-Procedure Planning
Imaging & Labs
- MR lymphangiography if available (heavily T2-weighted sequences) — map lymphatic anatomy and identify potential leak site before procedure
- Review prior CT chest/abdomen/pelvis — assess for adequate-sized inguinal lymph nodes (intranodal approach), cisterna chyli location, effusion/ascites distribution
- Confirm chylous nature of effusion: triglycerides ≥110 mg/dL = chylous; presence of chylomicrons is confirmatory
- Patients not taking enteral nutrition or on low-fat diet may not meet TG criteria but still may have chyle leak
Patient Preparation
- NPO or low-fat diet to reduce chyle flow (improves leak visualization)
- Preprocedural US of bilateral inguinal regions to confirm adequate lymph node targets (intranodal approach)
- Position supine on fluoroscopy table — wedge under upper back for comfort
- Ensure chest tube (if present) is secured and excluded from sterile field
- Scout radiographs of abdomen and chest (including obliques) before contrast injection — subtle early opacification can be missed without baseline
Relevant Anatomy
Lymphatic System Course
- Pedal lymphatics → run along medial dorsum of foot, ascend medial leg and thigh
- Inguinal lymph nodes → iliac chain lymph nodes (progression slows through numerous nodes)
- Retroperitoneal lymphatics → converge into the cisterna chyli (L1–L2, anterior to vertebral body)
- Cisterna chyli → gives rise to the thoracic duct, which ascends through the posterior mediastinum
- Thoracic duct → drains into the left subclavian/internal jugular vein junction (lymphovenous junction)
Thoracic Duct Anatomy & Variants
- Thoracic duct is the largest lymphatic vessel in the body; drains majority of body lymph
- Originates from cisterna chyli at L1–L2, courses rightward then crosses midline at ~T5 to the left
- Multiple anatomic variants exist — duplicated ducts, right-sided drainage, or plexiform networks rather than single channel
- Right lymphatic duct drains right upper body — separate system, smaller
- Injury most common during thoracic surgery near the duct (esophagectomy, spine surgery, mediastinal dissection)
Intranodal Access Anatomy
Inguinal lymph nodes are targeted for intranodal access. On US, the needle tip should be positioned at the junction of the lymph node cortex and medulla to reduce extravasation risk. Positioning the needle in the hilum risks injection into the lymph node vein rather than efferent lymphatics. Through-and-through puncture or puncturing the same node more than once should be avoided, as contrast extravasation reduces efficiency of intralymphatic progression. A bilateral approach is universally used for intranodal technique.
Technique
Intranodal Lymphangiography (Preferred Technique)
Assemble Needle-Syringe System
Sterile Prep & US-Guided Nodal Access
Test & Begin Lipiodol Injection
Monitor Progression Under Fluoroscopy
Identify Leak & Complete
Pedal Lymphangiography (Traditional Technique)
Blue Dye Injection
Pedal Cutdown & Lymphatic Cannulation
Lipiodol Infusion
Closure
Community Cards
Key Landmarks
Cisterna Chyli
- Located at L1–L2, anterior to vertebral body
- Confluence of lumbar lymphatic trunks and intestinal trunk
- Target for thoracic duct access during embolization
- Opacifies with Lipiodol as a pooling structure in retroperitoneum
- Best visualized on 15–20° left posterior oblique fluoroscopy
Thoracic Duct Course
- Arises from cisterna chyli, enters thorax through aortic hiatus
- Ascends in posterior mediastinum, typically right of midline initially
- Crosses midline at approximately T5 level to the left
- Courses posterior to aortic arch and left subclavian artery
- Multiple variants exist — may be plexiform rather than single channel
Lymphovenous Junction
- Thoracic duct drains into junction of left subclavian vein and left internal jugular vein
- This is the endpoint of Lipiodol transit — stop injection if oil enters venous system
- Right lymphatic duct drains into right venous angle (separate, smaller system)
- Leak sites between cisterna chyli and this junction are targets for embolization
Troubleshooting
Lipiodol Not Ascending Through Lymphatics
Inject additional volume slowly (do not exceed 0.2 mL/kg total). Be patient — progression through pelvis is characteristically slow due to traversal of numerous iliac chain nodes. Massage medial leg and thigh to manually push oil centrally. Consider reverse Trendelenburg positioning. If using pedal approach, ensure needle has not dislodged. After adequate Lipiodol volume, switch to saline to push the contrast column further.
Cannot Access Inguinal Lymph Node
Reposition US probe and try a different inguinal lymph node — look for the largest available node. Use shallow-angle approach with skin entry ≥2 cm from transducer for better needle visualization. Small nodes significantly reduce success. If bilateral intranodal access fails, consider switching to pedal lymphangiography.
Lipiodol Leaking Around Node Rather Than Into Lymphatics
Avoid through-and-through puncture of the node. Do not puncture the same node more than once. Carefully reposition needle tip within the node cortex (not hilum). If extravasation continues, try a different lymph node. The 25G needle limits injection rate, which reduces extravasation risk.
Cannot Cannulate Pedal Lymphatic
Ensure adequate blue dye has been taken up (wait longer if needed). Use magnification loupes for better visualization. Try slightly blunting needle tip on sterile towel to prevent double-walling the lymphatic. If lymphatic is transected during dissection, extend incision and attempt a more proximal segment. If pedal approach fails entirely, switch to intranodal technique.
Lymphangiogram Does Not Demonstrate Leak Site
Leak may have sealed spontaneously. Consider high-fat meal or enteral feeding challenge to provoke chyle flow and unmask the leak. Obtain delayed imaging at 24 hours (Lipiodol persists in lymphatics) — delayed extravasation may become apparent. Even without visible leak, Lipiodol itself may be therapeutic (sclerosing effect seals leak in ~50% of cases).
Complications
Major Complications
- Fat (oil) embolism — Lipiodol enters pulmonary venous system; limit dose to 0.2 mL/kg (max ~20 mL in adults); stop infusion if Lipiodol enters venous circulation; risk increased with right-to-left shunts or prior lung radiation
- Pulmonary oil embolism / pneumonitis — rare with controlled injection and dose limits; presents with dyspnea, hypoxia; supportive care
- Cerebral oil embolism — extremely rare; risk with right-to-left cardiac shunt or prior mediastinal radiation
- Allergic reaction — to Lipiodol (iodinated oil) or isosulfan blue dye; standard anaphylaxis management
Minor Complications
- Granuloma at injection site — foreign body reaction to Lipiodol; usually self-limited
- Wound complications (pedal approach) — infection, lymph leak from cutdown site, delayed healing; careful silk tie removal and closure technique
- Perinodal extravasation (intranodal) — oil contrast leaking around node; limits effectiveness but generally benign
- Blue discoloration of skin/urine — from isosulfan blue dye (pedal approach); transient, resolves spontaneously
- Connector hub degradation — oil contrast may degrade plastic tubing; monitor connections for leaks during infusion
Pearls & Pitfalls
References & Resources
Key Technique Points
- Intranodal technique: position needle at cortex-medulla junction; inject at ~1 mL/5 min per side
- Pedal technique: infuse Lipiodol at 8–12 mL/h via power injector set to mL/hour
- Total Lipiodol limited to 0.2 mL/kg (~20 mL in adults); substitute saline to propel column further
Primary References
- Stecker MS, Fan C-M. Lymphangiography for thoracic duct interventions. Tech Vasc Interventional Rad. 2016;19:277–285. DOI: 10.1053/j.tvir.2016.10.010
- Itkin M, Kucharczuk JC, Kwak A, et al. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg. 2010;139(3):584–590.
- Nadolski GJ, Itkin M. Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization. J Vasc Interv Radiol. 2012;23(5):613–616.
- Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. J Vasc Interv Radiol. 1998;9(5):727–734.